The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002
Abstract
Background— In the United States and Canada, folic acid fortification of enriched grain products was fully implemented by 1998. The resulting population-wide reduction in blood homocysteine concentrations might be expected to reduce stroke mortality if high homocysteine levels are an independent risk factor for stroke. Methods and Results— In this population-based cohort study with quasi-experimental intervention, we used segmented log-linear regression to evaluate trends in stroke-related mortality before and after folic acid fortification in the United States and Canada and, as a comparison, during the same period in England and Wales, where fortification is not required. Average blood folate concentrations increased and homocysteine concentrations decreased in the United States after fortification. The ongoing decline in stroke mortality observed in the United States between 1990 and 1997 accelerated in 1998 to 2002 in nearly all population strata, with an overall change from −0.3% (95% CI, −0.7 to 0.08) to −2.9 (95% CI, −3.5 to −2.3) per year ( P =0.0005). Sensitivity analyses indicate that changes in other major recognized risk factors are unlikely to account for the reduced number of stroke-related deaths in the United States. The fall in stroke mortality in Canada averaged −1.0% (95% CI, −1.4 to −0.6) per year from 1990 to 1997 and accelerated to −5.4% (95% CI, −6.0 to −4.7) per year in 1998 to 2002 ( P ≤0.0001). In contrast, the decline in stroke mortality in England and Wales did not change significantly between 1990 and 2002. Conclusions— The improvement in stroke mortality observed after folic acid fortification in the United States and Canada but not in England and Wales is consistent with the hypothesis that folic acid fortification helps to reduce deaths from stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Continuing Epidemics of Obesity and Diabetes in the United States
Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730
Hajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,946
Feigin, V. L., Lawes, C. M., Bennett, D. A., & Anderson, C. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00266-7 · Cited by 1,932
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
Jacques, P. F., Selhub, J., Bostom, A. G., Wilson, P. W. F., & Rosenberg, I. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401901 · Cited by 1,117
Rothwell, P., Coull, A., Giles, M., Howard, S., Silver, L., Bull, L., Gutnikov, S., Edwards, P., Mant, D., Sackley, C., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16405-2 · Cited by 1,094
Impact of Folic Acid Fortification of the US Food Supply on the Occurrence of Neural Tube Defects
Honein, M. A. (2001) · JAMA · doi:10.1001/jama.285.23.2981 · Cited by 1,066
Araki, A., & Sako, Y. (1987) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(87)80438-3 · Cited by 1,041
Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults
Gregg, E. W. (2005) · JAMA · doi:10.1001/jama.293.15.1868 · Cited by 959
Sorlie, P. D., Backlund, E., & Keller, J. B. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.7.949 · Cited by 833
Cooper, R., Cutler, J., Desvigne-Nickens, P., Fortmann, S. P., Friedman, L., Havlik, R., Hogelin, G., Marler, J., McGovern, P., Morosco, G., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3137 · Cited by 831
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.
D'Agostino, R. B., Wolf, P. A., Belanger, A. J., & Kannel, W. B. (1994) · Stroke · doi:10.1161/01.str.25.1.40 · Cited by 712
Hunink, M. G. M. (1997) · JAMA · doi:10.1001/jama.277.7.535 · Cited by 679
(2001) · PubMed · Cited by 612
Gorelick, P. B., Sacco, R. L., Smith, D. B., Alberts, M., Mustone-Alexander, L., Rader, D., Ross, J. L., Raps, E., Ozer, M. N., Brass, L. M., et al. (1999) · JAMA · doi:10.1001/jama.281.12.1112 · Cited by 473
Temporal trends in overweight and obesity in Canada, 1981–1996
Tremblay, M., Katzmarzyk, P., & Willms, J. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801923 · Cited by 445
Homocysteine and stroke: evidence on a causal link from mendelian randomisation
Casas, J. P., Bautista, L. E., Smeeth, L. L., Sharma, P. K., & Hingorani, A. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17742-3 · Cited by 444
Pfeiffer, C. M., Huff, D. L., & Gunter, E. W. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.2.290 · Cited by 373
Ford, E. S., Mokdad, A. H., Giles, W. H., & Mensah, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000066320.27195.b4 · Cited by 357
Decline in the Prevalence of Spina Bifida and Anencephaly by Race/Ethnicity: 1995–2002
Williams, L. J., Rasmussen, S. A., Flores, A., Kirby, R. S., & Edmonds, L. D. (2005) · Pediatrics · doi:10.1542/peds.2005-0592 · Cited by 320
New Evidence for Stroke Prevention: Scientific Review
Straus, S. E., Majumdar, S. R., & McAlister, F. A. (2002) · JAMA · doi:10.1001/jama.288.11.1388 · Cited by 295
Pocock, S. J., McCormack, V., Gueyffier, F., Boutitie, F., Fagard, R. H., & Boissel, J.-P. (2001) · BMJ · doi:10.1136/bmj.323.7304.75 · Cited by 272
Newborn Intensive Care and Neonatal Mortality in Low-Birth-Weight Infants: A Population Study
Paneth, N., Kiely, J. L., Wallenstein, S., Marcus, M., Pakter, J., & Susser, M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207153070303 · Cited by 259
Botto, L. D., Lisi, A., Robert-Gnansia, E., Erickson, J. D., Vollset, S. E., Mastroiacovo, P., Botting, B., Cocchi, G., de Vigan, C., de Walle, H., et al. (2005) · BMJ · doi:10.1136/bmj.38336.664352.82 · Cited by 246
Self-citationVitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
Spence, J. D., Bang, H., Chambless, L. E., & Stampfer, M. J. (2005) · Stroke · doi:10.1161/01.str.0000185929.38534.f3 · Cited by 244
Cronin, S., Furie, K. L., & Kelly, P. J. (2005) · Stroke · doi:10.1161/01.str.0000169946.31639.af · Cited by 168
Decline in Deaths From Heart Disease and Stroke—United States, 1900-1999
(1999) · JAMA · doi:10.1001/jama.282.8.724 · Cited by 161
Grundy, S. M., D’Agostino, R. B., Mosca, L. J., Burke, G. L., Wilson, P. W. F., Rader, D. J., Cleeman, J. I., Roccella, E. J., Cutler, J. A., & Friedman, L. M. (2001) · Circulation · doi:10.1161/01.cir.104.4.491 · Cited by 157
Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota
Davis, P. H., Dambrosia, J. M., Schoenberg, B. S., SCHOENBERG, D. G., Pritchard, D. A., Lilienfeld, A. M., & Whisnant, J. P. (1987) · Annals of Neurology · doi:10.1002/ana.410220307 · Cited by 156
Altitude, Low Birth Weight, and Infant Mortality in Colorado
Unger, C. A., Weiser, J. K., McCullough, R. E., Keefer, S., & Moore, L. G. (1988) · JAMA · doi:10.1001/jama.1988.03720230037027 · Cited by 142
Neural tube defect rates before and after food fortification with folic acid
Mills, J. L., & Signore, C. C. (2004) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20075 · Cited by 140
Risk factors for cardiovascular disease in Canada.
Tanuseputro, P., Manuel, D. G., Leung, M., Nguyen, K., & Johansen, H. (2003) · PubMed · Cited by 139
Self-citationTrends in Stroke Prevalence Between 1973 and 1991 in the US Population 25 to 74 Years of Age
Muntner, P., Garrett, E., Klag, M. J., & Coresh, J. (2002) · Stroke · doi:10.1161/01.str.0000015031.57955.d1 · Cited by 139
Major Risk Factors for Cardiovascular Disease: Debunking the "Only 50%" Myth
Canto, J. G., & Iskandrian, A. E. (2003) · JAMA · doi:10.1001/jama.290.7.947 · Cited by 135
Trend of Stroke Hospitalization, United States, 1988–1997
Fang, J., & Alderman, M. (2001) · Stroke · doi:10.1161/hs1001.096193 · Cited by 132
Mark, S. D., Wang, W., Fraumeni, J. F., Li, J., Taylor, P. R., Wang, G.-Q., Guo, W., Dawsey, S. M., Li, B., & Blot, W. J. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008798 · Cited by 123
Ray, J. G., Vermeulen, M. J., Boss, S. C., & Cole, D. E. C. (2002) · Epidemiology · doi:10.1097/00001648-200203000-00026 · Cited by 96
Greenlund, K. J., Zheng, Z. J., Keenan, N. L., Giles, W. H., Casper, M. L., Mensah, G. A., & Croft, J. B. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.2.181 · Cited by 88
The Impact of the Canadian Hypertension Education Program on Antihypertensive Prescribing Trends
Campbell, N. R. C., Tu, K., Brant, R., Duong-Hua, M., & McAlister, F. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000196269.98463.fd · Cited by 66
Folate status in women of childbearing age, by race/ethnicity--United States, 1999-2000.
(2002) · PubMed · Cited by 60
Use of cholesterol-lowering medications in the United States from 1991 to 1997
Siegel, D., Lopez, J., & Meier, J. L. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00319-3 · Cited by 56
Griffiths, C., Brock, A., & Rooney, C. (2004) · PubMed · Cited by 30
Trends in Hospital Admission for Stroke in Calgary
Field, T. S., Green, T., Roy, K., Pedersen, J., & Hill, M. D. (2004) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003504 · Cited by 29
The population approach to stroke prevention: a Canadian perspective.
Young, T. K., & Hachinski, V. (2003) · PubMed · Cited by 14
Miriuka, S., Langman, L. J., Keren, E. S., Miner, S. E. S., Mamer, O., Delgado, D., Evrovski, J., Ross, H. J., & Cole, D. E. C. (2004) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(03)00202-x · Cited by 11
Cited by
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Is folic acid good for everyone?
Smith, A. D., Kim, Y.-I., & Refsum, H. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.517 · Cited by 612
Efficacy of folic acid supplementation in stroke prevention: a meta-analysis
Wang, X., Qin, X., Demirtas, H., Li, J., Mao, G., Huo, Y., Sun, N., Liu, L., & Xu, X. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60854-x · Cited by 589
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.348 · Cited by 498
Refsum, H., Nurk, E., David Smith, A., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygård, O., & Vollset, S. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1731s · Cited by 493
Metadata
- Authors
- Yang, Q., Botto, L. D., Erickson, J. D., Berry, R. J., Sambell, C., Johansen, H., & Friedman, J. M.
- Venue
- Circulation
- Published
- 2006-03-14
- Volume
- 113
- Issue
- 10
- Pages
- 1335-1343
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1983803438
- Cited by
- 335
- References
- 48
- FWCI
- 28.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.